LYR-210

DRUG3 trials

Sponsors

Lyra Therapeutics

Conditions

Chronic Rhinosinusitis (Diagnosis)Chronic Sinusitis

Phase 2

LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)

CompletedNCT04041609

Lyra TherapeuticsChronic Rhinosinusitis (Diagnosis), Chronic Sinusitis

Start: 2019-05-09End: 2021-02-04Updated: 2023-07-25

Phase 3

Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

CompletedNCT05219968

Lyra TherapeuticsChronic Rhinosinusitis (Diagnosis), Chronic Sinusitis

Start: 2022-01-27End: 2024-09-16Updated: 2025-05-02

Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)

CompletedNCT05295459

Lyra TherapeuticsChronic Rhinosinusitis (Diagnosis), Chronic Sinusitis

Start: 2022-05-13End: 2025-04-02Updated: 2026-02-19

Related Papers

Impact of long‐acting implantable LYR‐210 corticosteroid matrices on quality of life of patients with chronic rhinosinusitis in the LANTERN study

International Forum of Allergy & Rhinology2023-02-082 citations